Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Vortioxetin Hydrobromid Tabletten Verwendung
Es gibt vier Spezifikationen für Vortioxetin: 5 mg, 10 mg, 15 mg, 20 mg. Vortioxetinhydrobromid gilt als neues Multi-Modell-Antidepressivum. In-vitro-Studien haben gezeigt, dass es 5-HT3-, 5-HT7- und 5-HT1D-Rezeptoren antagonisieren, 5-HT1A-Rezeptoren aktivieren und den 5-HT1B-Rezeptor teilweise aktivieren und den 5-HT-Transport hemmen kann. Vortioxetinhydrobromid ist eine neue Art von Bisarylsulfanylamin Antidepressivum, das gemeinsam von Takeda Japan und Lingbei, Dänemark, entwickelt wurde. Es wird zur Behandlung von Depressionen und Angstzuständen eingesetzt.
Items | Standards | Results |
Appearance | White to light-yellow solid | Complies |
Identification | By IR | Complies |
By HPLC | Complies | |
Loss on Drying | ≤0.50% | 0.30% |
Heavy Metals | ≤20ppm | Complies |
Residue on Ignition | ≤0.10% | 0.04% |
Related Substances | Maximum single impurity: ≤0.10% | 0.05% |
Total Impurities: ≤1.00% | 0.08% | |
Assay (HPLC basis on drying) |
98.0%~102.0% | 99.93% |
Reference Standard | In-house Standard | |
Conclusion | The product complied to In-house standard. | |
Storage | Preserve in tight,light-resistant containers in a cool place |
Produktgruppe : Vortioxetinhydrobromid
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.